If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "Medipace"
Jump to navigation
Jump to search
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 10: | Line 10: | ||
[[Brain Computer Interface Classification|BCI Categories]]: Open-Loop Afferent | [[Brain Computer Interface Classification|BCI Categories]]: Open-Loop Afferent | ||
| + | |||
| + | [[:Category:Neurostimulation_Techniques|Neurostimulation Technique(s)]]: SNS | ||
==Links== | ==Links== | ||
[http://medipaceinc.com/ Website] | [http://medipaceinc.com/ Website] | ||
[https://www.linkedin.com/company/medipace-inc/ LinkedIn] | [https://www.linkedin.com/company/medipace-inc/ LinkedIn] | ||
Revision as of 19:38, 7 March 2022
"pursuing bioelectronic neuromodulation therapies for metabolic, digestive, and auto-immune diseases."
Founded in The United States around 2018, Medipace produces invasive hardware.
Medipace makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): SNS